Reinventing Yourself With Multiple Sclerosis (MS): An Intervention Aimed at Improving Self-Efficacy, Coping, Psychological Well-being, and Quality of Life in MS

Status unknownNot a drug-phase studyMS (type not specified)NCT05195320

We could not find results for this trial

What it found

No results found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • Reinvention with MS

What it measured

Main measures

  • Multiple Sclerosis Self-Efficacy Scale

    Through study completion, an average of 6 months

  • General Self-Efficacy Scale

    Through study completion, an average of 6 months

Other measures (9)

  • Health Status Questionnaire

    Through study completion, an average of 6 months

    Pain
  • Satisfaction with Life Scale

    Through study completion, an average of 6 months

    Quality of life (reported by participants)
  • Ryff Psychological Well-being Scales

    Through study completion, an average of 6 months

    Quality of life (reported by participants)
  • Participation Assessment with Recombined Tools-Objective (PART-O)

    Through study completion, an average of 6 months

  • Chicago Multiscale Depression Inventory

    Through study completion, an average of 6 months

    Mood and sleep
  • State Trait Anxiety Scale

    Through study completion, an average of 6 months

    Mood and sleep
  • Connor-Davidson Resilience Scale

    Through study completion, an average of 6 months

  • Benefit Finding in Multiple Sclerosis Scale

    Through study completion, an average of 6 months

  • Cope Inventory

    Through study completion, an average of 6 months

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

* Diagnosis of multiple sclerosis * 18 years of age or older * English-speaking * Able to provide informed consent * Access to the internet (if needed should the groups have to be conducted online due to pandemic circumstances that may limit to in-person meetings).

Exclusion criteria

* History of any other neurological illness (e.g. traumatic brain injury, epilepsy, dementia) * Cognitive impairment that would affect my ability to fully participate in the group * (For in-person group): Live beyond a reasonable commuting distance (50+ miles) * Any other medical or psychological condition that, in the judgement of the investigators, prevents successful participation in the study

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Given the knowledge that detriments in QOL, well-being, and participation are common in MS and attributable in a large part to individual, person-specific factors (e.g., self-efficacy), efforts to develop interventions aimed at addressing these factors is well needed and likely to have a significant impact. The proposed investigation will consist of two phases involving participant recruitment and data collection. Phase 1 will consist of a focus group aimed at identifying the unique needs of individuals with MS, and findings will be used to adapt the Reinventing Yourself after Spinal Cord Injury (SCI) intervention to Reinventing Yourself with MS. Phase 2 will consist of a randomized controlled trial (RCT) in which the feasibility and efficacy of the intervention in a new population can be examined.

Loading reviews and guidelines…

History

    1. Started

      Aug 2022

    2. Main results due

      Sept 2024

    3. Finished

      Sept 2024

    Assembled by software from public sources.